314 related articles for article (PubMed ID: 20231062)
1. Outcome and prognostic factors in olfactory neuroblastoma: a rare cancer network study.
Ozsahin M; Gruber G; Olszyk O; Karakoyun-Celik O; Pehlivan B; Azria D; Roelandts M; Kaanders JH; Cengiz M; Krengli M; Matzinger O; Zouhair A
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):992-7. PubMed ID: 20231062
[TBL] [Abstract][Full Text] [Related]
2. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
3. [Long-term experiences in the therapy of esthesioneuroblastoma].
Koch M; Constantinidis J; Dimmler A; Strauss C; Iro H
Laryngorhinootologie; 2006 Oct; 85(10):723-30. PubMed ID: 16673299
[TBL] [Abstract][Full Text] [Related]
4. Treatment modalities and outcomes of olfactory neuroblastoma.
Song CM; Won TB; Lee CH; Kim DY; Rhee CS
Laryngoscope; 2012 Nov; 122(11):2389-95. PubMed ID: 23070733
[TBL] [Abstract][Full Text] [Related]
5. Multimodality therapy including radiotherapy and chemotherapy improves event-free survival in stage C esthesioneuroblastoma.
Eich HT; Hero B; Staar S; Micke O; Seegenschmiedt H; Mattke A; Berthold F; Müller RP
Strahlenther Onkol; 2003 Apr; 179(4):233-40. PubMed ID: 12707712
[TBL] [Abstract][Full Text] [Related]
6. Olfactory neuroblastoma: the University of Erlangen-Nuremberg experience 1975-2000.
Constantinidis J; Steinhart H; Koch M; Buchfelder M; Schaenzer A; Weidenbecher M; Iro H
Otolaryngol Head Neck Surg; 2004 May; 130(5):567-74. PubMed ID: 15138422
[TBL] [Abstract][Full Text] [Related]
7. Therapy and prognosis of intracranial invasive olfactory neuroblastoma.
Jiang GY; Li FC; Chen WK; Liu AM; Cai WQ
Otolaryngol Head Neck Surg; 2011 Dec; 145(6):951-5. PubMed ID: 21825099
[TBL] [Abstract][Full Text] [Related]
8. Esthesioneuroblastoma: the Northwestern University experience.
Argiris A; Dutra J; Tseke P; Haines K
Laryngoscope; 2003 Jan; 113(1):155-60. PubMed ID: 12514401
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic factors and outcome of esthesioneuroblastoma].
Zhao LJ; Gao L; Xu GZ; Li SY; Xiao GL
Zhonghua Zhong Liu Za Zhi; 2005 Sep; 27(9):561-4. PubMed ID: 16438858
[TBL] [Abstract][Full Text] [Related]
10. Radiation therapy for esthesioneuroblastoma: rationale for elective neck irradiation.
Monroe AT; Hinerman RW; Amdur RJ; Morris CG; Mendenhall WM
Head Neck; 2003 Jul; 25(7):529-34. PubMed ID: 12808655
[TBL] [Abstract][Full Text] [Related]
11. Esthesioneuroblastoma in childhood and adolescence. Better prognosis with multimodal treatment?
Eich HT; Müller RP; Micke O; Kocher M; Berthold F; Hero B
Strahlenther Onkol; 2005 Jun; 181(6):378-84. PubMed ID: 15925980
[TBL] [Abstract][Full Text] [Related]
12. Olfactory neuroblastoma: the 22-year experience at one comprehensive cancer center.
Diaz EM; Johnigan RH; Pero C; El-Naggar AK; Roberts DB; Barker JL; DeMonte F
Head Neck; 2005 Feb; 27(2):138-49. PubMed ID: 15654688
[TBL] [Abstract][Full Text] [Related]
13. Combined modality therapy of esthesioneuroblastoma.
McLean JN; Nunley SR; Klass C; Moore C; Müller S; Johnstone PA
Otolaryngol Head Neck Surg; 2007 Jun; 136(6):998-1002. PubMed ID: 17547995
[TBL] [Abstract][Full Text] [Related]
14. Long-term results of 28 esthesioneuroblastomas managed over 35 years.
de Gabory L; Abdulkhaleq HM; Darrouzet V; Bébéar JP; Stoll D
Head Neck; 2011 Jan; 33(1):82-6. PubMed ID: 20848423
[TBL] [Abstract][Full Text] [Related]
15. Esthesioneuroblastoma: the University of Iowa experience 1978-1998.
Simon JH; Zhen W; McCulloch TM; Hoffman HT; Paulino AC; Mayr NA; Buatti JM
Laryngoscope; 2001 Mar; 111(3):488-93. PubMed ID: 11224781
[TBL] [Abstract][Full Text] [Related]
16. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
17. Esthesioneuroblastoma: is there a need for elective neck treatment?
Demiroz C; Gutfeld O; Aboziada M; Brown D; Marentette LJ; Eisbruch A
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e255-61. PubMed ID: 21676553
[TBL] [Abstract][Full Text] [Related]
18. [A retrospective study about 11 cases of Esthesioneuroblastomas treated in Hospital Santa Creu i Sant Pau between 2000 and 2008 and literature review].
Muñoz F; Tresserras P; Montserrat JR; Sancho FJ; Bartumeus F
Neurocirugia (Astur); 2011 Oct; 22(5):401-17; discussion 417-8. PubMed ID: 22031159
[TBL] [Abstract][Full Text] [Related]
19. Early or up-front radiotherapy improved survival of localized extranodal NK/T-cell lymphoma, nasal-type in the upper aerodigestive tract.
Huang MJ; Jiang Y; Liu WP; Li ZP; Li M; Zhou L; Xu Y; Yu CH; Li Q; Peng F; Liu JY; Luo F; Lu Y
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):166-74. PubMed ID: 17919841
[TBL] [Abstract][Full Text] [Related]
20. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
